img

Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Research Report 2024

There are commercial vaccines available containing either a live modified PRRS virus or a dead PRRS virus, both of which are used to increase the immunity to these strains of the infection. These vaccines are licensed in both breeding or growing pigs.
According to Mr Accuracy reports new survey, global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market is projected to reach US$ 696.7 million in 2029, increasing from US$ 363 million in 2022, with the CAGR of 10.2% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market research.
Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


CAHIC
Boehringer Ingelheim
MSD Animal Health
Sino Pharm
Ceva
ChengDu Tecbond
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Phibro Animal Health
Tecon
Zoetis
WINSUN
PULILE
Segment by Type
Live Vaccines
Killed Vaccines

Segment by Application


Government Tender
Market Sales

Consumption by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Overview
1.1 Product Overview and Scope of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines
1.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Type
1.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Value Comparison by Type (2024-2034)
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Application
1.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Value by Application: (2024-2034)
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Estimates and Forecasts
1.4.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue 2018-2029
1.4.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales 2018-2029
1.4.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Competition by Manufacturers
2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Manufacturers (2018-2024)
2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Average Price by Manufacturers (2018-2024)
2.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Product Type & Application
2.7 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Competitive Situation and Trends
2.7.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Players Market Share by Revenue
2.7.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Retrospective Market Scenario by Region
3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region: 2018-2029
3.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region: 2018-2024
3.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region: 2024-2029
3.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region: 2018-2029
3.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region: 2018-2024
3.3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region: 2024-2029
3.4 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Facts & Figures by Country
3.4.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2018-2029)
3.4.3 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2018-2029)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Facts & Figures by Country
3.5.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2018-2029)
3.5.3 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2018-2029)
3.6.3 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Facts & Figures by Country
3.7.1 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2018-2029)
3.7.3 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2018-2029)
3.8.3 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2018-2029)
4.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2018-2024)
4.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2024-2029)
4.1.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2018-2029)
4.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2018-2024)
4.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2024-2029)
4.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2018-2029)
5 Segment by Application
5.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2029)
5.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2024)
5.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2024-2029)
5.1.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2018-2029)
5.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2018-2024)
5.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2024-2029)
5.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2018-2029)
6 Key Companies Profiled
6.1 CAHIC
6.1.1 CAHIC Corporation Information
6.1.2 CAHIC Description and Business Overview
6.1.3 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.1.4 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.1.5 CAHIC Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 MSD Animal Health
6.3.1 MSD Animal Health Corporation Information
6.3.2 MSD Animal Health Description and Business Overview
6.3.3 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.3.4 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.3.5 MSD Animal Health Recent Developments/Updates
6.4 Sino Pharm
6.4.1 Sino Pharm Corporation Information
6.4.2 Sino Pharm Description and Business Overview
6.4.3 Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.4.5 Sino Pharm Recent Developments/Updates
6.5 Ceva
6.5.1 Ceva Corporation Information
6.5.2 Ceva Description and Business Overview
6.5.3 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.5.5 Ceva Recent Developments/Updates
6.6 ChengDu Tecbond
6.6.1 ChengDu Tecbond Corporation Information
6.6.2 ChengDu Tecbond Description and Business Overview
6.6.3 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.6.4 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.6.5 ChengDu Tecbond Recent Developments/Updates
6.7 Ringpu Biology
6.6.1 Ringpu Biology Corporation Information
6.6.2 Ringpu Biology Description and Business Overview
6.6.3 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.7.5 Ringpu Biology Recent Developments/Updates
6.8 Qilu Animal
6.8.1 Qilu Animal Corporation Information
6.8.2 Qilu Animal Description and Business Overview
6.8.3 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.8.5 Qilu Animal Recent Developments/Updates
6.9 DHN
6.9.1 DHN Corporation Information
6.9.2 DHN Description and Business Overview
6.9.3 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.9.4 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.9.5 DHN Recent Developments/Updates
6.10 CAVAC
6.10.1 CAVAC Corporation Information
6.10.2 CAVAC Description and Business Overview
6.10.3 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.10.4 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.10.5 CAVAC Recent Developments/Updates
6.11 Komipharm
6.11.1 Komipharm Corporation Information
6.11.2 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
6.11.3 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.11.5 Komipharm Recent Developments/Updates
6.12 Agrovet
6.12.1 Agrovet Corporation Information
6.12.2 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
6.12.3 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.12.5 Agrovet Recent Developments/Updates
6.13 Bioveta
6.13.1 Bioveta Corporation Information
6.13.2 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
6.13.3 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.13.5 Bioveta Recent Developments/Updates
6.14 Jinyu Bio-Technology
6.14.1 Jinyu Bio-Technology Corporation Information
6.14.2 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
6.14.3 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.14.5 Jinyu Bio-Technology Recent Developments/Updates
6.15 Phibro Animal Health
6.15.1 Phibro Animal Health Corporation Information
6.15.2 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
6.15.3 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.15.5 Phibro Animal Health Recent Developments/Updates
6.16 Tecon
6.16.1 Tecon Corporation Information
6.16.2 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
6.16.3 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.16.5 Tecon Recent Developments/Updates
6.17 Zoetis
6.17.1 Zoetis Corporation Information
6.17.2 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
6.17.3 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.17.5 Zoetis Recent Developments/Updates
6.18 WINSUN
6.18.1 WINSUN Corporation Information
6.18.2 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
6.18.3 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.18.4 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.18.5 WINSUN Recent Developments/Updates
6.19 PULILE
6.19.1 PULILE Corporation Information
6.19.2 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
6.19.3 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.19.4 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.19.5 PULILE Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Chain Analysis
7.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production Mode & Process
7.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Marketing
7.4.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Channels
7.4.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors
7.5 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Customers
8 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Dynamics
8.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Trends
8.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Drivers
8.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Challenges
8.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Competitive Situation by Manufacturers in 2022
Table 4. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units) of Key Manufacturers (2018-2024)
Table 5. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Average Price (USD/K Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2018-2024) & (M Units)
Table 18. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2018-2024)
Table 19. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2024-2029) & (M Units)
Table 20. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2024-2029)
Table 21. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region (2018-2024)
Table 23. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region (2024-2029)
Table 25. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2018-2024) & (M Units)
Table 27. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2024-2029) & (M Units)
Table 28. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2018-2024) & (M Units)
Table 32. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2024-2029) & (M Units)
Table 33. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2018-2024) & (M Units)
Table 37. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2024-2029) & (M Units)
Table 38. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2018-2024) & (M Units)
Table 42. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2024-2029) & (M Units)
Table 43. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2018-2024) & (M Units)
Table 47. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2024-2029) & (M Units)
Table 48. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units) by Type (2018-2024)
Table 51. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units) by Type (2024-2029)
Table 52. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2018-2024)
Table 53. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2024-2029)
Table 54. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2018-2024)
Table 57. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2024-2029)
Table 58. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price (USD/K Unit) by Type (2018-2024)
Table 59. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price (USD/K Unit) by Type (2024-2029)
Table 60. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units) by Application (2018-2024)
Table 61. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units) by Application (2024-2029)
Table 62. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2018-2024)
Table 63. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2024-2029)
Table 64. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2018-2024)
Table 67. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2024-2029)
Table 68. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price (USD/K Unit) by Application (2018-2024)
Table 69. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price (USD/K Unit) by Application (2024-2029)
Table 70. CAHIC Corporation Information
Table 71. CAHIC Description and Business Overview
Table 72. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 73. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 74. CAHIC Recent Developments/Updates
Table 75. Boehringer Ingelheim Corporation Information
Table 76. Boehringer Ingelheim Description and Business Overview
Table 77. Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 78. Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 79. Boehringer Ingelheim Recent Developments/Updates
Table 80. MSD Animal Health Corporation Information
Table 81. MSD Animal Health Description and Business Overview
Table 82. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 83. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 84. MSD Animal Health Recent Developments/Updates
Table 85. Sino Pharm Corporation Information
Table 86. Sino Pharm Description and Business Overview
Table 87. Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 88. Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 89. Sino Pharm Recent Developments/Updates
Table 90. Ceva Corporation Information
Table 91. Ceva Description and Business Overview
Table 92. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 93. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 94. Ceva Recent Developments/Updates
Table 95. ChengDu Tecbond Corporation Information
Table 96. ChengDu Tecbond Description and Business Overview
Table 97. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 98. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 99. ChengDu Tecbond Recent Developments/Updates
Table 100. Ringpu Biology Corporation Information
Table 101. Ringpu Biology Description and Business Overview
Table 102. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 103. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 104. Ringpu Biology Recent Developments/Updates
Table 105. Qilu Animal Corporation Information
Table 106. Qilu Animal Description and Business Overview
Table 107. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 108. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 109. Qilu Animal Recent Developments/Updates
Table 110. DHN Corporation Information
Table 111. DHN Description and Business Overview
Table 112. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 113. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 114. DHN Recent Developments/Updates
Table 115. CAVAC Corporation Information
Table 116. CAVAC Description and Business Overview
Table 117. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 118. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 119. CAVAC Recent Developments/Updates
Table 120. Komipharm Corporation Information
Table 121. Komipharm Description and Business Overview
Table 122. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 123. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 124. Komipharm Recent Developments/Updates
Table 125. Agrovet Corporation Information
Table 126. Agrovet Description and Business Overview
Table 127. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 128. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 129. Agrovet Recent Developments/Updates
Table 130. Bioveta Corporation Information
Table 131. Bioveta Description and Business Overview
Table 132. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 133. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 134. Bioveta Recent Developments/Updates
Table 135. Jinyu Bio-Technology Corporation Information
Table 136. Jinyu Bio-Technology Description and Business Overview
Table 137. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 138. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 139. Jinyu Bio-Technology Recent Developments/Updates
Table 140. Phibro Animal Health Corporation Information
Table 141. Phibro Animal Health Description and Business Overview
Table 142. Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 143. Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 144. Phibro Animal Health Recent Developments/Updates
Table 145. Tecon Corporation Information
Table 146. Tecon Description and Business Overview
Table 147. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 148. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 149. Tecon Recent Developments/Updates
Table 150. Zoetis Corporation Information
Table 151. Zoetis Description and Business Overview
Table 152. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 153. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 154. Zoetis Recent Developments/Updates
Table 155. WINSUN Corporation Information
Table 156. WINSUN Description and Business Overview
Table 157. WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 158. WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 159. WINSUN Recent Developments/Updates
Table 160. PULILE Corporation Information
Table 161. PULILE Description and Business Overview
Table 162. PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 163. PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 164. PULILE Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors List
Table 168. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Customers List
Table 169. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Trends
Table 170. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Drivers
Table 171. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Challenges
Table 172. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines
Figure 2. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Type in 2022 & 2029
Figure 4. Live Vaccines Product Picture
Figure 5. Killed Vaccines Product Picture
Figure 6. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Application in 2022 & 2029
Figure 8. Government Tender
Figure 9. Market Sales
Figure 10. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size (2018-2029) & (US$ Million)
Figure 12. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (2018-2029) & (M Units)
Figure 13. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Average Price (USD/K Unit) & (2018-2029)
Figure 14. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Report Years Considered
Figure 15. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Share by Manufacturers in 2022
Figure 16. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Players: Market Share by Revenue in 2022
Figure 18. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2018-2029)
Figure 21. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Country (2018-2029)
Figure 22. the United States Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2018-2029)
Figure 25. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Country (2018-2029)
Figure 26. Germany Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. UK Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region (2018-2029)
Figure 33. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2018-2029)
Figure 43. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Type (2018-2029)
Figure 53. Global Revenue Market Share of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Type (2018-2029)
Figure 54. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price (USD/K Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Application (2018-2029)
Figure 56. Global Revenue Market Share of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Application (2018-2029)
Figure 57. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price (USD/K Unit) by Application (2018-2029)
Figure 58. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Value Chain
Figure 59. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries